India has leveraged its manufacturing capacity to pre-order 600 million doses of potential Covid-19 vaccine and negotiating for another billion doses, says a new global analysis of advance market commitments (AMC) for vaccine candidates against the coronavirus.
The total number of these vaccine doses, if they are approved to be utilised in the course of time, should be enough to vaccine half of the country’s over 1.3 billion population given the fact that most of the vaccine candidates against the coronavirus require two doses. Read More…
